213 related articles for article (PubMed ID: 17360658)
21. IRF5 regulates airway macrophage metabolic responses.
Albers GJ; Iwasaki J; McErlean P; Ogger PP; Ghai P; Khoyratty TE; Udalova IA; Lloyd CM; Byrne AJ
Clin Exp Immunol; 2021 Apr; 204(1):134-143. PubMed ID: 33423291
[TBL] [Abstract][Full Text] [Related]
22. Specific detection of interferon regulatory factor 5 (IRF5): A case of antibody inequality.
Li D; De S; Li D; Song S; Matta B; Barnes BJ
Sci Rep; 2016 Aug; 6():31002. PubMed ID: 27481535
[TBL] [Abstract][Full Text] [Related]
23. IRF5 deficiency ameliorates lupus but promotes atherosclerosis and metabolic dysfunction in a mouse model of lupus-associated atherosclerosis.
Watkins AA; Yasuda K; Wilson GE; Aprahamian T; Xie Y; Maganto-Garcia E; Shukla P; Oberlander L; Laskow B; Menn-Josephy H; Wu Y; Duffau P; Fried SK; Lichtman AH; Bonegio RG; Rifkin IR
J Immunol; 2015 Feb; 194(4):1467-79. PubMed ID: 25595782
[TBL] [Abstract][Full Text] [Related]
24. Regulation of immunity and oncogenesis by the IRF transcription factor family.
Savitsky D; Tamura T; Yanai H; Taniguchi T
Cancer Immunol Immunother; 2010 Apr; 59(4):489-510. PubMed ID: 20049431
[TBL] [Abstract][Full Text] [Related]
25. The interferon regulatory factor family in host defense: mechanism of action.
Ozato K; Tailor P; Kubota T
J Biol Chem; 2007 Jul; 282(28):20065-9. PubMed ID: 17502370
[TBL] [Abstract][Full Text] [Related]
26. Interferon regulatory factors IRF5 and IRF7 inhibit growth and induce senescence in immortal Li-Fraumeni fibroblasts.
Li Q; Tang L; Roberts PC; Kraniak JM; Fridman AL; Kulaeva OI; Tehrani OS; Tainsky MA
Mol Cancer Res; 2008 May; 6(5):770-84. PubMed ID: 18505922
[TBL] [Abstract][Full Text] [Related]
27. Multifaceted contribution of the TLR4-activated IRF5 transcription factor in systemic sclerosis.
Saigusa R; Asano Y; Taniguchi T; Yamashita T; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Sugawara K; Tsuruta D; Taniguchi T; Sato S
Proc Natl Acad Sci U S A; 2015 Dec; 112(49):15136-41. PubMed ID: 26598674
[TBL] [Abstract][Full Text] [Related]
28. IRF5, IRF8, and IRF7 in human pDCs - the good, the bad, and the insignificant?
Pelka K; Latz E
Eur J Immunol; 2013 Jul; 43(7):1693-7. PubMed ID: 23828296
[TBL] [Abstract][Full Text] [Related]
29. IRF5-mediated immune responses and its implications in immunological disorders.
Kaur A; Lee LH; Chow SC; Fang CM
Int Rev Immunol; 2018; 37(5):229-248. PubMed ID: 29985675
[TBL] [Abstract][Full Text] [Related]
30. Dual Role of p53 in Innate Antiviral Immunity.
Rivas C; Aaronson SA; Munoz-Fontela C
Viruses; 2010 Jan; 2(1):298-313. PubMed ID: 21994612
[TBL] [Abstract][Full Text] [Related]
31. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses.
Krausgruber T; Blazek K; Smallie T; Alzabin S; Lockstone H; Sahgal N; Hussell T; Feldmann M; Udalova IA
Nat Immunol; 2011 Mar; 12(3):231-8. PubMed ID: 21240265
[TBL] [Abstract][Full Text] [Related]
32. IRF5 Is Required for Bacterial Clearance in Human M1-Polarized Macrophages, and
Hedl M; Yan J; Witt H; Abraham C
J Immunol; 2019 Feb; 202(3):920-930. PubMed ID: 30593537
[TBL] [Abstract][Full Text] [Related]
33. Role of interferon regulatory factor 5 (IRF5) in tumor progression: Prognostic and therapeutic potential.
Roberts BK; Collado G; Barnes BJ
Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189061. PubMed ID: 38141865
[TBL] [Abstract][Full Text] [Related]
34. IRF5 governs liver macrophage activation that promotes hepatic fibrosis in mice and humans.
Alzaid F; Lagadec F; Albuquerque M; Ballaire R; Orliaguet L; Hainault I; Blugeon C; Lemoine S; Lehuen A; Saliba DG; Udalova IA; Paradis V; Foufelle F; Venteclef N
JCI Insight; 2016 Dec; 1(20):e88689. PubMed ID: 27942586
[TBL] [Abstract][Full Text] [Related]
35. [Function of tumor suppressor p53 and its role in antiviral immunity].
Yan WJ; Wu KB; Ma ZY
Bing Du Xue Bao; 2012 Jun; 28(4):462-70. PubMed ID: 22978174
[TBL] [Abstract][Full Text] [Related]
36. IRF5 guides monocytes toward an inflammatory CD11c
Corbin AL; Gomez-Vazquez M; Berthold DL; Attar M; Arnold IC; Powrie FM; Sansom SN; Udalova IA
Sci Immunol; 2020 May; 5(47):. PubMed ID: 32444476
[TBL] [Abstract][Full Text] [Related]
37. Control of virus infection by tumour suppressors.
Muñoz-Fontela C; García MA; Collado M; Marcos-Villar L; Gallego P; Esteban M; Rivas C
Carcinogenesis; 2007 Jun; 28(6):1140-4. PubMed ID: 17347139
[TBL] [Abstract][Full Text] [Related]
38. Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization.
Wang M; Hoo Lim K; Chow KT
J Vis Exp; 2019 Oct; (152):. PubMed ID: 31633694
[TBL] [Abstract][Full Text] [Related]
39. Activation and function of interferon regulatory factor 5.
Ryzhakov G; Eames HL; Udalova IA
J Interferon Cytokine Res; 2015 Feb; 35(2):71-8. PubMed ID: 25259415
[TBL] [Abstract][Full Text] [Related]
40. The adjuvanticity of manganese for microbial vaccines via activating the IRF5 signaling pathway.
Cui C; Wang S; Lu W; Wang Y; Li J; Qu K; Yang M; Wang L; Yu Y
Biochem Pharmacol; 2021 Oct; 192():114720. PubMed ID: 34363796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
